The current finding, in conjunction with our recent studies [13,15] in the effects of ARB, antioxidant or NFκB inhibition on endothelial function, vascular inflammation and CV injury strongly suggest that Ang II/ROS activation of NFκB is an important link among hypertension, vascular injury and insulin resistance. Here, NFKB1 is linked to Hypertension.